Geir Christian Melen is the Chief Financial Officer of Zelluna Immunotherapy. He has extensive management experience from the biotech industry including serving as the CEO of Ostomycure and Clavis Pharma, as well as the CFO of Algeta and Photocure. Over his professional career, he has gained extensive experience in financing, strategy and corporate development. During his tenure at Algeta and Photocure, he was responsible for IPO of the companies and in addition he has been responsible for several other fund raising events for the various companies he has worked for. He also has solid business development experience including holding key roles in Clavis Pharma and Photocure while they entered into substantial licensing agreements. Previously positions also include CFO of two petroleum companies, Acumen Energy and Tellus Petroleum. He holds a Master of Science in Business and administration from the Norwegian School of Economics and is a Norwegian citizen.